 reuters    u s  democratic senator claire mccaskill on thursday expanded an investigation into the causes of the opioid crisis plaguing the country  seeking information from four more drugmakers and three drug distributors  the top ranking democrat on the senate homeland security and governmental affairs committee is focusing on the distribution of opioids and the efforts companies made to report and investigate the diversion of drugs for illicit use  the investigation comes at a time when lawmakers and regulators take steps to combat the epidemic of opioid addiction  with  americans dying everyday as a result of overdose  according to the u s  centers for disease control and prevention       mccaskill requested for documents and information from opioid manufacturers mallinckrodt plc  endo international plc  teva pharmaceutical and allergan plc  in march  mccaskill asked johnson   johnson  mylan nv  purdue pharma  insys therapeutics inc and depomed inc for internal estimates of the risk of abuse  addiction and overdose of opioids  the senator also sent a request to mckesson corp  amerisourcebergen corp and cardinal health inc  focusing on their distribution of opioid products   mccaskill also requested for information on compensation provided that is in any way derived from revenue or profitability targets for sales of opioid products   we appreciate senator mccaskill s inquiry and look forward to thoughtfully answering her questions   a mckesson spokeswoman said in an email  adding that there was no link between the sale of controlled substances and incentive compensation for the company s executives       amerisourcebergen said it would respond to the letter from the senator  adding it provides daily reports to the regulators about the quantity  type and receiving pharmacy of every single order of controlled substances it distributes  endo said it received the letter and would provide the senator with the requested information  allergan said it is working with the senator s office to provide the requested information  the company also said its two branded opioid products   norco and kadian   account for   percent or less of all opioids prescribed in the united states  israel based teva in an email said it is committed to the  appropriate use of opioids and responsible pain management   mallinckrodt confirmed receipt of senator mccaskill s request for information  adding it has previously met with and provided information to her staff and would continue working with her office  the company noted it manufactures  only generic and non promoted branded opioids   cardinal health declined to comment  